Publications


Validation of SUV thresholds in [¹⁸F]SiTATE PET/CT for accurate meningioma segmentation

23.07.2025

Mansour N, JoramJ, Grawe F, Hinterberger A, Rübenthaler J, Kunz WG, Winkelmann M, Cyran CC, Ricke J, Öcal O, Unterrainer M, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Nitschmann A, Greve T, Sheikh G, Holzgreve A, Albert NL, Fabritius MP (2025) Validation of SUV Thresholds in [¹⁸F]SiTATE PET/CT for Accurate Meningioma Segmentation. European Journal

... read more

A modular AI-supported dosimetry system for real-time scatter radiation monitoring and visualization in hybrid operating rooms

29.05.2025

P. Schülein, N. Rettig, L. Marxen, N. Rathmann, S. Diehl, M. Vetter, “A modular AI-supported dosimetry system for real-time scatter radiation monitoring and visualization in hybrid operating rooms”, CARS 2025—Computer Assisted Radiology and Surgery Proceedings of the 39th International Congress and Exhibition Berlin, Germany, June 17–20, 2025. Int J CARS 20 (Suppl 1), 1–115 (2025). https://doi.org/10.1007/s11548-025-03373-6

... read more

AI-driven interactive avatars for supporting communication in clinical and preoperative settings

29.05.2025

A. Meyer, N. Rathmann, S. Diehl, M. Vetter, “AI-driven interactive avatars for supporting communication in clinical and preoperative settings”, CARS 2025—Computer Assisted Radiology and Surgery Proceedings of the 39th International Congress and Exhibition Berlin, Germany, June 17–20, 2025. Int J CARS 20 (Suppl 1), 1–115 (2025). https://doi.org/10.1007/s11548-025-03373-6

... read more

Development and Clinical Potential of 18F-PSiMA for Prostate Cancer PET Imaging.

09.05.2025

Gower-Fry L, Bailey JJ, Wuest M, Pike S, Kostikov A, Dorian A, Wängler C, Wuest F, Schirrmacher R (2025) Development and Clinical Potential of 18F-PSiMA for Prostate Cancer PET Imaging. RSC Medicinal Chemistry, 16(8), 3633–3644. DOI: 10.1039/d5md00275c. Abstract Prostate-specific membrane antigen (PSMA) is a key target for diagnosing prostate cancer through positron emission tomography (PET).

... read more

Structured reporting of neuroendocrine tumors in PET/CT using [18F]SiTATE – impact on interdisciplinary communication

08.02.2025

Hinterberger A, Trupka L, Kortbein S-V, Ebner R, Fink N, Frölich M, Nörenberg D, Wängler C, Wängler B, Schirrmacher R, Holzgreve A, Brendel M, Corradini M, Auernhammer C, Rübenthaler J, Grawe F (2025) Structured Reporting of Neuroendocrine Tumors (NET) in PET/CT using [18F]SiTATE – Impact on Quality and Interdisciplinary Communication. Scientific Reports, 15(1), 4793.DOI: 10.1038/s41598-025-88999-x Abstract

... read more

EAGLE: an edge-aware gradient localization enhanced loss for CT image reconstruction

30.01.2025

Yipeng Sun, Yixing Huang, Zeyu Yang, Linda-Sophie Schneider, Mareike Thies, Mingxuan Gu, Siyuan Mei, Siming Bayer, Frank G. Zöllner, and Andreas Maier “EAGLE: an edge-aware gradient localization enhanced loss for CT image reconstruction,” Journal of Medical Imaging 12(1), 014001 (22 January 2025). https://doi.org/10.1117/1.JMI.12.1.014001 Purpose We aim to enhance deep learning-based computed tomography (CT) image reconstructions.

... read more

Are 3D Tumor Cell Spheroids a Utile System for the In Vitro Evaluation of Diagnostic Radiotracers?

16.12.2024

Judmann B, Keller F, Wängler B, Schirrmacher R, Rudolf R, Wängler C* (2024) Are 3D tumor cell spheroids a utile system for the in vitro evaluation of diagnostic radiotracers? ACS Omega, 9(52), 51349–51362. DOI: 10.1021/acsomega.4c08214 Abstract: By possibly bridging the gap between 2D in vitro cell assays and in vivo applications, tumor cell spheroid cultures offer promising avenues for

... read more

Truncated NPY-based NPY(Y1)R-specific radiopeptides: Improved in vivo PET tumor imaging by application of peptidase inhibitors

01.12.2024

Judmann B, Baier NF, Rudolf H, Davarci G, Wängler B, Schirrmacher R, Fricker G, Wängler C* (2024) Truncated NPY-based NPY(Y1)R-specific radiopeptides: Improved in vivo PET tumor imaging by application of peptidase inhibitors. European Journal of Medicinal Chemistry Reports, 12, 100223.DOI: 10.1016/j.cellin.2024.100223 Abstract: The neuropeptide Y receptor subtype 1 (NPY(Y1)R) exhibits high expression rates on human breast cancer

... read more

Lenticulostriatal Ischemia Shows Relevant SSTR Expression on PET/CT Imaging Using the Novel SSTR-Targeting Peptide 18 F-SiTATE

01.12.2024

Kunte SC, Unterrainer LM, Kunz WG, Winkelmann M, Lindner S, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Bartenstein P, Belka C, Schichor C, Albert NL, Unterrrainer M (2024) Lenticulostriatal ischemia shows relevant SSTR-expression on PET/CT imaging using the novel SSTR-targeting peptide [18F]SiTATE. Clinical Nuclear Medicine, 49(12), e689–e690. DOI:: 10.1097/RLU.0000000000005482 Abstract A 64-year-old woman with meningioma

... read more

PET/CT imaging of differentiated and medullary thyroid carcinoma using the novel SSTR-targeting peptide [18F]SiTATE – first clinical experiences

15.10.2024

Kunte SC, Wenter V, Toms J, Lindner S, Unterrainer M, Eilsberger F, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Tiling MW, Sheikh GT, Mehrens D, Brendel M, Rübenthaler J, Auernhammer CJ, Spitzweg C, Unterrainer LM, Holzgreve A (2025) PET/CT imaging of differentiated and medullary thyroid carcinoma using the novel SSTR-targeting peptide [18F]SiTATE – first

... read more